News About

Aeterna Zentaris Announces "At-the-Market" Issuance Program

Tue, 21 May 2013 16:53:00 -0400

Traders Get Bullish on Shares of AEterna Zentaris, Shares Up 7.2% (AEZS)

Thu, 16 May 2013 11:53:00 -0400

Aeterna Zentaris to Present at Upcoming Bloom Burton & Co. Healthcare Investor Conference in Toronto

Wed, 15 May 2013 07:30:00 -0400

Aeterna Zentaris Announces Election of Directors at its Annual Meeting of Shareholders

Wed, 08 May 2013 16:06:56 -0400

Aeterna Zentaris (NASDAQ: AEZS) announces the results of the vote on directors held earlier today at its annual meeting of shareholders. Issuers listed on the Toronto Stock Exchange are required to issue a news release providing this information.

Each of the director nominees proposed by management for election

Aeterna Zentaris Announces Election of Directors at its Annual Meeting of Shareholders

Wed, 08 May 2013 16:05:00 -0400

Aeterna Zentaris Reports First Quarter 2013 Financial and Operating Results

Tue, 07 May 2013 16:44:00 -0400

Aeterna Zentaris to Announce First Quarter 2013 Financial and Operating Results on May 7, 2013 and Hold Annual Shareholders Meeting on May 8, 2013

Wed, 01 May 2013 07:30:00 -0400

Aeterna Zentaris Newly Appointed CEO, David A. Dodd, to Host Introductory Analyst and Investor Conference Call on Thursday, April 25, 2013

Tue, 23 Apr 2013 16:10:00 -0400

Aeterna Zentaris (AEZS) to Transfer Manufacturing Rights of Cetrotide

Wed, 17 Apr 2013 07:34:18 -0400

Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8258438 for the full story.

Aeterna Zentaris Announces Transfer of Manufacturing Rights Related to Cetrotide® to Merck KGaA

Wed, 17 Apr 2013 07:30:00 -0400

Aeterna Zentaris (AEZS) Names David Dodd as CEO

Mon, 15 Apr 2013 08:02:24 -0400

Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8251862 for the full story.

David A. Dodd Appointed President & Chief Executive Officer of Aeterna Zentaris Inc.

Mon, 15 Apr 2013 08:00:00 -0400

Traders Get Bullish on Shares of AEterna Zentaris, Shares Up 6.3% (AEZS)

Thu, 11 Apr 2013 11:24:00 -0400

Zumiez, Inc. (NASDAQ:ZUMZ), MEI Pharma, Inc. (NASDAQ:MEIP), and Aeterna Zentaris Inc. (NASDAQ:AEZS) Added to Growing Stock Report's NASDAQ Gainers Watch List.

Thu, 11 Apr 2013 10:45:47 -0400

New York, NY -- (SBWIRE) -- 04/11/2013 -- Growing Stock Report expands its NASDAQ Gainers Weekly Watch List adding Zumiez, Inc. (NASDAQ:ZUMZ), MEI Pharma, Inc. (NASDAQ:MEIP), and Aeterna Zentaris Inc. (NASDAQ:AEZS).

Aeterna Zentaris (AEZS) Presents Updated Proof-Of-Concept on Disorazol Z Cytotoxic Conjugates

Wed, 10 Apr 2013 17:47:16 -0400

Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8246314 for the full story.

Aeterna Zentaris Issues Encouraging Updated Data on LHRH Receptor-Targeted Disorazol Z Cytotoxic Conjugates

Wed, 10 Apr 2013 17:44:01 -0400

Aeterna Zentaris Inc. (NASDAQ: AEZS) (the "Company") today presented encouraging updated proof-of-concept results for Disorazol Z cytotoxic conjugates, such as AEZS-125 and AEZS-138, in human ovarian and endometrial cancer xenograft models. Results further showed the compounds' high potential for the treatment of luteinizing hormone-releasing hormone ("LHRH") receptor positive tumors. Data were presented earlier today

Aeterna Zentaris Presents Encouraging Updated Data on its LHRH Receptor-Targeted Disorazol Z Cytotoxic Conjugates at AACR Meeting

Wed, 10 Apr 2013 16:05:00 -0400

Aeterna Zentaris (AEZS), Ergomed Enter Co-Development Agreement for AEZS-108

Wed, 10 Apr 2013 07:31:37 -0400

Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8243875 for the full story.

Aeterna Zentaris and Ergomed Sign Co-Development and Profit Sharing Agreement for AEZS-108 in Endometrial Cancer

Wed, 10 Apr 2013 07:30:00 -0400

Aeterna Zentaris to Present Update on its LHRH Receptor-Targeted Disorazol Z Cytotoxic Conjugates at Upcoming AACR Annual Meeting

Wed, 03 Apr 2013 07:30:00 -0400

Telenav, Inc. (NASDAQ:TNAV), Aeterna Zentaris Inc. (NASDAQ:AEZS), and Amarin Corporation Plc (NASDAQ:AMRN) Added to Growing Stock Report's NASDAQ Decliners Watch List

Mon, 25 Mar 2013 17:19:59 -0400

New York, NY -- (SBWIRE) -- 03/25/2013 -- Growing Stock Report expands its NASDAQ Decliners Weekly Watch List adding Telenav, Inc. (NASDAQ:TNAV), Aeterna Zentaris Inc. (NASDAQ:AEZS), and Amarin Corporation plc (NASDAQ:AMRN).

American Public Education, Inc. (NASDAQ:APEI) and Aeterna Zentaris Inc. (NASDAQ:AEZS) Added to Growing Stock Report's NASDAQ Gainers Watch List.

Fri, 22 Mar 2013 12:58:19 -0400

New York, NY -- (SBWIRE) -- 03/22/2013 -- Growing Stock Report expands its NASDAQ Gainers Weekly Watch List adding American Public Education, Inc. (NASDAQ:APEI) and Aeterna Zentaris Inc. (NASDAQ:AEZS).

Aeterna Zentaris, Inc. (AEZS) Tops Q4 EPS by 2c

Thu, 21 Mar 2013 17:11:24 -0400

Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8204880 for the full story.

Aeterna Zentaris Reports Fourth Quarter and Full-Year 2012 Financial and Operating Results

Thu, 21 Mar 2013 16:19:00 -0400

Trading Radar for 03/21: Nike (NKE), lululemon (LULU), Micron (MU), KB Home (KBH) Report

Wed, 20 Mar 2013 15:25:22 -0400

Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8201046 for the full story.

Stocks in News: Lifevantage Corporation, AEterna Zentaris Inc, Skilled Healthcare Group, Osiris Therapeutics

Wed, 20 Mar 2013 13:54:49 -0400

Lakeway, TX -- (SBWIRE) -- 03/20/2013 -- Bestdamnpennystocks, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks.

Biotech Movers: Spectrum, AEterna Among Big Losers

Mon, 18 Mar 2013 04:47:36 -0400

Stocks to Track: AEterna Zentaris Inc, Ulta Salon, Cosmetics & Fragrance, Infosys Ltd, AK Steel Holding Corporation

Wed, 13 Mar 2013 09:34:16 -0400

Dallas, TX -- (SBWIRE) -- 03/13/2013 -- Marketbuzzreport.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks.

FDA's New "Breakthrough" Designation Allows New Drugs to Gain Approval After Just 1 Round of Testing

Wed, 13 Mar 2013 08:20:00 -0400

Five Star Equities Provides Stock Research on AEterna Zentaris and Amicus Therapeutics

Aeterna Zentaris to Present at Upcoming Roth 25th Annual OC Growth Stock Conference

Wed, 13 Mar 2013 07:30:00 -0400

Zynga Shares Rise on Yahoo Buyout Speculation. Can the Market Keep Up the 7 Day Bull Rally?

Tue, 12 Mar 2013 10:30:00 -0400

Aeterna Zentaris Inc (NASDAQ:AEZS) and Canadian Solar Inc. (NASDAQ:CSIQ) Added to Growing Stock Report's NASDAQ Decliners Watch List.

Tue, 12 Mar 2013 08:17:15 -0400

New York, NY -- (SBWIRE) -- 03/12/2013 -- Growing Stock Report expands its NASDAQ Decliners Weekly Watch List adding Aeterna Zentaris Inc (NASDAQ:AEZS) and Canadian Solar Inc. (NASDAQ:CSIQ).

Free Research Reports on AEZS, AMPE, ELN and MDCO Issued by the Bedford Report

Tue, 12 Mar 2013 08:15:00 -0400

Note to Editors: The Following Is an Investment Opinion Being Issued by the Equity News Circuit

Aeterna Zentaris to Announce Fourth Quarter and Full Year 2012 Financial and Operating Results on March 21, 2013

Tue, 12 Mar 2013 07:30:00 -0400

Aeterna Zentaris Ends Study

Mon, 11 Mar 2013 17:14:40 -0400

Aeterna Zentaris Inc. (Nasdaq: AEZS) will end a Phase 3 study of its multiple myeloma treatment perifosine sending the stock price plummeting 59 cents to close at $2.03....

CANADA STOCKS-TSX advances as energy shares, BlackBerry drive gains

Mon, 11 Mar 2013 16:58:02 -0400

* TSX rises 22.88 points, or 0.18 percent, to 12,858.49 * Six of 10 main sectors advance * Aeterna falls 22 pct after plan to halt cancer drug trial By John Tilak TORONTO, March 11 (Reuters) - Canada's main stock index closed higher on Monday, helped by gains in the energy sector and a 14 percent jump in BlackBerry shares on takeover speculation and U.S. market launch plans. BlackBerry shares gained after U.S. wireless carrier AT&T Inc said it would start selling the highly

Stocks to Eyes On: AEterna Zentaris, Nevsun Resources, Power Holdings, Affymax, BRF Brasil Foods

Mon, 11 Mar 2013 14:52:09 -0400

Lakeway, TX -- (SBWIRE) -- 03/11/2013 -- vbtrendreport.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks

Unusual 11 Mid-Day Movers 03/11: (CALI) (ESYS) (VRS) Higher; (AEZS) (CSIQ) (JRCC) Lower

Mon, 11 Mar 2013 13:51:25 -0400

Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8173776 for the full story.

Markets Advance At Midday

Mon, 11 Mar 2013 13:50:25 -0400

The markets advanced during the midday with the Dow rising 26 points to 14,423. Nasdaq eased a point to 3243.

Stock to Watch: AEterna Zentaris Down 29.0% (AEZS)

Mon, 11 Mar 2013 12:52:00 -0400

Market Close: Big Winners & Losers for March 11, 2013

Mon, 11 Mar 2013 12:25:00 -0400

DailyFinance.com: Here are today's five biggest gaining stocks at closing: China Auto Logistics Inc. (NASDAQ: CALI) is up 88.8% at $5.21. B.O.S. Better Online Solutions Ltd. (NASDAQ: BOSC) is up 44.6% at $3.85. Elecsys Corp. (NASDAQ: ESYS) is up 32.2% at ... Read more

IIROC Trade Resumption - Aeterna Zentaris Inc.

Mon, 11 Mar 2013 12:23:00 -0400

IIROC Trade Halt - Aeterna Zentaris Inc.

Mon, 11 Mar 2013 12:17:00 -0400

AEterna Zentaris (AEZS) Resumes, Shares Sink

Mon, 11 Mar 2013 11:47:01 -0400

Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8173436 for the full story.

AEterna Zentaris (AEZS) to resume trading at 11:45am ET

Mon, 11 Mar 2013 11:19:05 -0400

Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8173342 for the full story.

UPDATE: Aeterna Zentaris to Discontinue Phase 3 Trial in Multiple Myeloma with Perifosine

Mon, 11 Mar 2013 11:17:20 -0400

Aeterna Zentaris Inc. (NASDAQ: AEZS) today announced that an independent Data Safety Monitoring Board ("DSMB") has recommended discontinuing the ongoing Phase 3 study comparing the efficacy and safety of perifosine to placebo when combined with bortezomib (Velcade(®)) and dexamethasone in patients with relapsed or relapsed/refractory multiple myeloma. Based on the outcome of its pre-planned interim analysis of

AEterna Zentaris (AEZS) to Discontinue Perifosine Phase 3 in Relapsed Multiple Myeloma

Mon, 11 Mar 2013 11:16:51 -0400

Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8173335 for the full story.

Aeterna Zentaris to Discontinue Phase 3 Trial in Multiple Myeloma with Perifosine Following Data Safety Monitoring Board Recommendation

Mon, 11 Mar 2013 11:15:00 -0400

AEterna Zentaris (AEZS) halted ffor news.

Mon, 11 Mar 2013 11:11:30 -0400

Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8173302 for the full story.

VFC's Stock House Stock Watch Wednesday, 6 March 2013

Wed, 06 Mar 2013 03:00:00 -0500